Ipodate
- TRADE NAMES: Bilivist; Oragrafin
- INDICATIONS: Cholecystography
- CLASS: Iodine-containing radiocontrast medium
- HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric